Home >> Research Area >>Chromatin/Epigenetics>>HDAC>> BML-210(CAY10433)

BML-210(CAY10433)

Novel HDAC inhibitor CAS# 537034-17-6

BML-210(CAY10433)

Catalog No. BCC6479----Order now to get a substantial discount!

Product Name & Size Price Stock
BML-210(CAY10433): 5mg $92 In Stock
BML-210(CAY10433): 10mg Please Inquire In Stock
BML-210(CAY10433): 20mg Please Inquire Please Inquire
BML-210(CAY10433): 50mg Please Inquire Please Inquire
BML-210(CAY10433): 100mg Please Inquire Please Inquire
BML-210(CAY10433): 200mg Please Inquire Please Inquire
BML-210(CAY10433): 500mg Please Inquire Please Inquire
BML-210(CAY10433): 1000mg Please Inquire Please Inquire
Related Products

Quality Control of BML-210(CAY10433)

Number of papers citing our products

Chemical structure

BML-210(CAY10433)

3D structure

Chemical Properties of BML-210(CAY10433)

Cas No. 537034-17-6 SDF Download SDF
PubChem ID 9543540 Appearance Powder
Formula C20H25N3O2 M.Wt 339.43
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 30 mg/mL (88.38 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name N'-(2-aminophenyl)-N-phenyloctanediamide
SMILES C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NC2=CC=CC=C2N
Standard InChIKey RFLHBLWLFUFFDZ-UHFFFAOYSA-N
Standard InChI InChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of BML-210(CAY10433)

DescriptionBML-210 is a novel HDAC inhibitor, and its mechanism of action has not been characterized. IC50 value: 5 μM[1] Target: HDAC4 In vitro: Cell cycle analysis indicated that HeLa cell treatment with 20 and 30 μM concentration of BML-210 increased the proportion of cells in G0/G1 phase, and caused accumulation in subG1, indicating that the cells are undergoing apoptosis[2]. BML-210 inhibits the growth of NB4 cells in dose- and time-dependent manner[3]. In vivo:

References:
[1]. Nimanthi Jayathilaka, et al. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Res. 2012 Jul; 40(12): 5378–5388. [2]. Veronika V. Borutinskaite, et al. Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells. Mol Biol Rep (2012) 39:10179–10186 [3]. Veronika Borutinskaite, et al. The Histone Deacetylase Inhibitor BML-210 Influences Gene and Protein Expression in Human Promyelocytic Leukemia NB4 Cells via Epigenetic Reprogramming. Int J Mol Sci. 2015 Aug; 16(8): 18252–18269.

BML-210(CAY10433) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

BML-210(CAY10433) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of BML-210(CAY10433)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.9461 mL 14.7306 mL 29.4612 mL 58.9223 mL 73.6529 mL
5 mM 0.5892 mL 2.9461 mL 5.8922 mL 11.7845 mL 14.7306 mL
10 mM 0.2946 mL 1.4731 mL 2.9461 mL 5.8922 mL 7.3653 mL
50 mM 0.0589 mL 0.2946 mL 0.5892 mL 1.1784 mL 1.4731 mL
100 mM 0.0295 mL 0.1473 mL 0.2946 mL 0.5892 mL 0.7365 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on BML-210(CAY10433)

BML-210 (CAY10433) is a novel HDAC inhibitor with IC50 value of 87 μM [1].

Histone deacetylases (HDACs) are a class of enzymes that remove acetyl groups from ε-N-acetyl lysines on histones, allowing the histones to wrap the DNA more tightly. DNA expression is regulated by de-acetylation and acetylation.

BML-210 (CAY10433) is a novel HDAC inhibitor. In FRDA lymphoid cell line (GM15850), BML-210 increased the level of FXN mRNA by 1.4-fold [1]. In the human leukemia cell lines (NB4, HL-60, THP-1, and K562), BML-210 induced G1 arrest and histone H4 acetylation, affected NF-κB and Sp1 binding to the p21 or the FasL promoters, and influenced expression of Sp1, NF-κB, p21 and FasL. BML-210 inhibited cell growth and induced apoptosis in a time- and dose-dependent way. BML-210 also induced K562 and HL-60 cell differentiation (up to 30%) to erythrocytes and granulocytes, respectively [2]. In HeLa cells, BML-210 (20 or 30 μM) increased the amount of cells in G0/G1 phase, caused sub-G1 accumulation, and induced apoptosis [3]. In human promyelocytic leukemia NB4 cells, BML-210 inhibited cell growth in a dose- and time-dependent way [4].

References:
[1].  Herman D, Jenssen K, Burnett R, et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol, 2006, 2(10): 551-558.
[2].  Savickiene J, Borutinskaite VV, Treigyte G, et al. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines. Eur J Pharmacol, 2006, 549(1-3): 9-18.
[3].  Borutinskaite VV, Magnusson KE, Navakauskiene R. Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells. Mol Biol Rep, 2012, 39(12): 10179-10186.
[4].  Borutinskaitė V, Navakauskienė R. The Histone Deacetylase Inhibitor BML-210 Influences Gene and Protein Expression in Human Promyelocytic Leukemia NB4 Cells via Epigenetic Reprogramming. Int J Mol Sci, 2015, 16(8): 18252-18269.

Featured Products
New Products
 

Description

BML-210 is a novel HDAC inhibitor, and its mechanism of action has not been characterized.

Keywords:

BML-210(CAY10433),537034-17-6,Natural Products,HDAC, buy BML-210(CAY10433) , BML-210(CAY10433) supplier , purchase BML-210(CAY10433) , BML-210(CAY10433) cost , BML-210(CAY10433) manufacturer , order BML-210(CAY10433) , high purity BML-210(CAY10433)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: